3DPOD Episode 153: 3D Printing Success with 3Doodler Inventor Max Bogue

RAPID

Share this Article

Today we interview Max Bogue, co-host of the 3DPOD. He tells us how he went from the genesis of the idea for a 3D printing pen to creating the product to founding the company 3Doodler. As major moments in his story, Max points to saying no to huge opportunities, having dogs in the office, and visiting factories. What follows is a great story and a lot of very practical advice, including good patent lawyers and the importance of different company structures , along with a lot more that will be helpful to entrepreneurs.

Share this Article


Recent News

Origin Shareholders Escalate Legal Battle Against Stratasys Over Earn-Out Payments

Former 3D Systems’ Exec Launches GenesisTissue for Bioprinting



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Stanford’s Dr. Skylar-Scott Breaks Down the Timeline for Fully Bioprinted Organs

Bioprinting has transitioned from an ambitious idea to a field making steady progress toward creating functional tissues and vascularized structures, offering a glimpse into the future of regenerative medicine. Against...

Can 3D Printing with Captured Carbon Help Address Climate Change?

It sounds almost too good to be true, but a recent study published in Nature Communications describes a potentially groundbreaking process where carbon dioxide (CO2) is converted into 3D-printed carbon...

Featured

American Axle & Manufacturing Acquires GKN Powder Metallurgy and GKN Automotive for $1.44B

American Axle & Manufacturing (AAM), a publicly listed supplier of automotive driveline and drivetrain components headquartered in Detroit, has acquired Dowlais Group plc, the parent company of GKN Automotive and...

Stanford’s $250 Bioprinter Makes Bioprinting Accessible to All

Bioprinting has long been praised as a groundbreaking tool for advancing regenerative medicine, drug testing, and tissue engineering. But despite its immense potential, the high cost of bioprinters has kept...